Revvity - 41 Year Stock Price History | RVTY
- The all-time high Revvity stock closing price was 199.71 on December 31, 2021.
- The Revvity 52-week high stock price is 128.83, which is 2.3% above the current share price.
- The Revvity 52-week low stock price is 82.17, which is 34.8% below the current share price.
- The average Revvity stock price for the last 52 weeks is 109.08.
Revvity Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2024 | 111.3245 | 110.1436 | 127.6753 | 99.2577 | 125.9600 | 15.53% |
2023 | 116.6316 | 140.4511 | 143.7509 | 81.8671 | 109.0265 | -21.86% |
2022 | 149.7563 | 190.9050 | 190.9050 | 116.3742 | 139.5356 | -30.13% |
2021 | 158.1494 | 144.2642 | 199.7054 | 119.3751 | 199.7054 | 40.37% |
2020 | 106.2368 | 97.7435 | 146.6437 | 66.0022 | 142.2714 | 48.19% |
2019 | 88.8494 | 75.8118 | 99.7459 | 71.7413 | 96.0034 | 24.01% |
2018 | 79.3809 | 72.5901 | 95.7922 | 70.8346 | 77.4183 | 7.80% |
2017 | 62.6675 | 51.8079 | 72.5214 | 50.4869 | 71.8142 | 40.85% |
2016 | 50.5789 | 50.9821 | 55.5767 | 40.3652 | 50.9866 | -2.12% |
2015 | 48.3112 | 42.6242 | 52.8588 | 41.2418 | 52.0906 | 23.21% |
2014 | 42.7635 | 39.3230 | 46.4935 | 38.4383 | 42.2762 | 6.75% |
2013 | 33.8183 | 30.5734 | 39.7168 | 29.0346 | 39.6015 | 30.96% |
2012 | 25.9897 | 19.4169 | 30.7639 | 19.2002 | 30.2399 | 60.41% |
2011 | 22.3228 | 24.1260 | 26.6552 | 16.4855 | 18.8514 | -21.62% |
2010 | 20.9312 | 18.9787 | 24.3496 | 17.5430 | 24.0515 | 27.04% |
2009 | 15.2954 | 12.8007 | 19.2332 | 9.9879 | 18.9327 | 50.67% |
2008 | 21.8581 | 22.7994 | 26.7298 | 11.8702 | 12.5658 | -45.92% |
2007 | 23.1140 | 19.3359 | 26.6018 | 18.9031 | 23.2369 | 18.34% |
2006 | 18.6635 | 20.9170 | 21.0595 | 15.7470 | 19.6362 | -4.41% |
2005 | 18.1940 | 19.0011 | 20.8036 | 15.5999 | 20.5421 | 6.19% |
2004 | 16.6180 | 14.8655 | 19.6893 | 13.4853 | 19.3452 | 33.79% |
2003 | 10.9410 | 7.2964 | 15.8142 | 6.1725 | 14.4589 | 112.10% |
2002 | 10.4258 | 28.0338 | 29.0193 | 3.6110 | 6.8171 | -75.70% |
2001 | 25.7940 | 38.5308 | 39.7622 | 17.0070 | 28.0578 | -32.73% |
2000 | 29.7228 | 16.3123 | 47.4684 | 15.3518 | 41.7086 | 154.15% |
1999 | 12.9899 | 11.1414 | 17.2452 | 10.0092 | 16.4107 | 52.59% |
1998 | 10.3019 | 7.8946 | 12.8834 | 7.4447 | 10.7547 | 36.69% |
1997 | 7.6855 | 7.3152 | 8.9371 | 6.7621 | 7.8682 | 6.28% |
1996 | 7.4708 | 8.5457 | 8.9157 | 6.0236 | 7.4035 | -14.69% |
1995 | 6.1276 | 5.0523 | 8.6781 | 4.6255 | 8.6781 | 77.85% |
1994 | 5.4504 | 5.9260 | 6.3919 | 4.7938 | 4.8795 | -20.48% |
1993 | 6.7642 | 6.4684 | 8.0260 | 5.3426 | 6.1363 | -3.88% |
1992 | 7.3688 | 7.7091 | 8.5022 | 5.8957 | 6.3838 | -19.47% |
1991 | 6.4309 | 4.9301 | 7.9274 | 4.8927 | 7.9274 | 64.01% |
1990 | 5.6020 | 5.2444 | 6.3054 | 4.3657 | 4.8335 | -6.48% |
1989 | 4.9094 | 4.2604 | 5.5302 | 4.2604 | 5.1684 | 20.77% |
1988 | 4.8042 | 4.9348 | 5.6377 | 4.0564 | 4.2797 | -11.97% |
1987 | 5.1312 | 4.1135 | 6.5160 | 4.1135 | 4.8617 | 18.19% |
1986 | 4.9572 | 5.5696 | 6.2059 | 4.0771 | 4.1135 | -26.39% |
1985 | 5.4695 | 4.5867 | 6.1884 | 4.5867 | 5.5885 | 21.38% |
1984 | 4.4794 | 4.6959 | 5.1866 | 3.8586 | 4.6042 | -2.71% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $15.535B | $2.751B |
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $96.890B | 12.02 |
Cencora (COR) | United States | $46.107B | 17.62 |
DiDi Global (DIDIY) | China | $23.233B | 0.00 |
ICON (ICLR) | Ireland | $18.679B | 16.64 |
Avantor (AVTR) | United States | $15.498B | 23.24 |
Natera (NTRA) | United States | $15.385B | 0.00 |
Viatris (VTRS) | United States | $13.858B | 4.22 |
BioMerieux (BMXMF) | France | $13.601B | 0.00 |
Solventum (SOLV) | United States | $12.636B | 0.00 |
CochLear (CHEOY) | Australia | $12.565B | 0.00 |
Medpace Holdings (MEDP) | United States | $10.202B | 28.74 |
Charles River Laboratories (CRL) | United States | $9.742B | 18.41 |
Sonic Healthcare (SKHHY) | Australia | $8.273B | 0.00 |
HealthEquity (HQY) | United States | $7.792B | 42.29 |
Doximity (DOCS) | United States | $7.787B | 49.34 |
Bausch + Lomb (BLCO) | Canada | $6.975B | 32.47 |
Life Times (LTH) | United States | $4.762B | 31.52 |
PACS (PACS) | United States | $4.502B | 0.00 |
Sotera Health (SHC) | United States | $4.367B | 23.36 |
Organon (OGN) | United States | $4.239B | 4.28 |
Surgery Partners (SGRY) | United States | $3.778B | 41.86 |
BrightSpring Health Services (BTSG) | United States | $3.070B | 65.30 |
Ardent Health Partners (ARDT) | United States | $2.577B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.546B | 0.00 |
Concentras Parent (CON) | United States | $2.480B | 0.00 |
Premier (PINC) | United States | $2.271B | 11.34 |
GoodRx Holdings (GDRX) | United States | $2.254B | 84.86 |
GeneDx Holdings (WGS) | United States | $2.057B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
Teladoc Health (TDOC) | United States | $1.575B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $1.507B | 7.57 |
Progyny (PGNY) | United States | $1.425B | 25.06 |
Establishment Labs Holdings (ESTA) | $1.338B | 0.00 | |
Pediatrix Medical (MD) | United States | $1.319B | 12.91 |
CareDx (CDNA) | United States | $1.228B | 0.00 |
Agilon Health (AGL) | United States | $1.123B | 0.00 |
Embecta (EMBC) | United States | $0.864B | 5.76 |
InnovAge Holding (INNV) | United States | $0.822B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
SBC Medicals (SBC) | United States | $0.722B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.488B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.483B | 0.00 |
Enhabit (EHAB) | United States | $0.382B | 33.04 |
DocGo (DCGO) | United States | $0.355B | 13.35 |
COMPASS Pathways (CMPS) | United Kingdom | $0.309B | 0.00 |
Sera Prognostics (SERA) | United States | $0.255B | 0.00 |
ModivCare (MODV) | United States | $0.232B | 7.37 |
Beauty Health (SKIN) | United States | $0.211B | 0.00 |
Biodesix (BDSX) | United States | $0.195B | 0.00 |
LifeMD (LFMD) | United States | $0.192B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.178B | 0.00 |
MultiPlan (MPLN) | United States | $0.136B | 0.00 |
Nutex Health (NUTX) | United States | $0.127B | 0.00 |
So-Young (SY) | China | $0.092B | 22.35 |
Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.059B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
OncoCyte (OCX) | United States | $0.049B | 0.00 |
NeueHealth (NEUE) | United States | $0.041B | 1.63 |
Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.036B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
Oncology Institute (TOI) | United States | $0.021B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
XWELL (XWEL) | United States | $0.009B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
KindlyMD (KDLY) | United States | $0.005B | 0.00 |
ISpecimen (ISPC) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.001B | 0.00 |